Optimized Outcomes

Regardless of the ownership structure, we act with the mentality of a shareholder advocate. We serve a broad spectrum of organizations, ranging from early stage, high growth companies to well-established, multi-billion dollar global corporations.

Signallamp Health Logo
- Merged With -
Accuhealth logo

Falcon Advises Signallamp Health in its Merger with AccuHealth, a Portfolio Investment of Sunstone Partners


Falcon Capital Partners, LLC (“Falcon”), a leading middle-market investment bank, is pleased to announce the merger of Signallamp Health, Inc. (“Signallamp”) with AccuHealth Technologies LLC (“AccuHealth”), a portfolio company of Sunstone Partners.

Signallamp Health, headquartered in Scranton, PA, is a leading healthcare company that helps hospitals and health systems Take Care Further™, with remote Chronic Care Management (“CCM”) that maximizes patient engagement to improve clinical outcomes and patient satisfaction and reduce the overall cost of care.

Sunstone Partners is a growth-oriented equity firm that invests in AI- and Technology-enabled services and software companies. The firm seeks to partner with exceptional management teams, often as their first institutional capital partner, to help accelerate organic growth and fund acquisitions. Founded in 2015, the firm has $1.7 billion committed capital to its three funds. Sunstone Partners has been recognized as one of Inc. Magazine’s “Founder-Friendly Investors” list in 2020, 2021, 2022 and 2023.

Sunstone is merging Signallamp with AccuHealth, a leading healthcare technology company offering comprehensive remote patient monitoring (“RPM”) and CCM solutions encompassing hardware, proprietary software and clinical monitoring, to physician practices and health systems throughout the United States. Sunstone Partners completed its initial growth investment into AccuHealth in April 2024.

The combination of Signallamp and AccuHealth will create a market leader in the CCM and RPM space, delivering patient centered solutions utilizing innovative “In-Home Clinical Technology” to facilitate data driven interventions.

Falcon served as the exclusive financial advisor to Signallamp. Ted Stack, Managing Director at Falcon, stated, “Falcon is thrilled to have assisted in a successful outcome for the shareholders of Signallamp and is excited to witness the next chapter for founders Drew Kearney and Andy Goldberg and the rest of the Signallamp team.”

Drew Kearney, Co-Founder and CEO of Signallamp stated “The Falcon team has been a true partner throughout our growth journey as both a strategic advisor and transaction execution specialist. Their understanding of the healthcare ecosystem played an important role in delivering a fantastic outcome for all parties involved. We couldn’t be happier with Ted and the entire Falcon team.”

The terms of the transaction were not disclosed. This transaction represents Falcon’s continued expertise in Healthcare Technology and Services. The Falcon deal team included Managing Director Ted Stack, Director Don Wanner, Vice President Steve Wasylenko and Senior Associate Ish Khan.

For more information, please contact us.

Ted Stack | tstack@falconllc.com
Don Wanner | dwanner@falconllc.com